Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cohance Lifesciences
Hyderabad, Telangana, Indiacohance.com ↗
- Ownership
- Private
- Employees
- ~1193
- Development stage
- Commercial
01
Overview
Cohance Lifesciences is a leading Indian CDMO and API platform offering end-to-end services from development to commercialization. The company supports global pharmaceutical innovators with process R&D, manufacturing of APIs/intermediates/formulations, clinical research services including bioavailability/bioequivalence studies, and has expanded technical capabilities via recent acquisitions in oligonucleotides and antibody-drug conjugates. It operates over 100 active projects across all phases of drug development.
- Modalities
- Small moleculeAntibody-drug conjugateOligonucleotide
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Cohance Lifesciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cohance Lifesciences.